Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB072A | — |
Only diluent administered; Only diluent administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 17-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB072A, expiry date 30-APR-2026) for prophylaxis. On 15-AUG-2025, the patient received Menveo. On 15-AUG-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Only diluent administered) and inappropriate dose of vaccine administered (Verbatim: Only diluent administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 15-AUG-2025 The reporter reported that patient came in for meningococcal vaccine today for school and most recently their facility have gotten 2 different kinds of Menveo (1 vial and 2 vial). The patient received 1 vial (diluent) of the 2 vial presentation of Menveo thinking it was the 1 vial presentation which led to inappropriate dose of vaccine administered and inappropriate preparation of medication.